May 23, 2017 1:37 PM ET

Healthcare Equipment and Supplies

Company Overview of Sensus Healthcare, Inc.

Company Overview

Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameter. The company also provides Sentinel service program, which offers its customers protection for their SRT-100 and SRT-100 Vision systems. In additi...

851 Broken Sound Parkway NW

Suite 215

Boca Raton, FL 33487

United States

Founded in 2010

37 Employees





Key Executives for Sensus Healthcare, Inc.

Chairman, Chief Executive Officer and President
Age: 63
Total Annual Compensation: $390.0K
Chief Financial Officer
Age: 58
Total Annual Compensation: $275.0K
Chief Operating Officer and Chief Technology Officer
Age: 45
Total Annual Compensation: $246.8K
Executive Vice President of Dermatology Sales & Marketing
Age: 56
Total Annual Compensation: $269.0K
Compensation as of Fiscal Year 2016.

Sensus Healthcare, Inc. Key Developments

Sensus Healthcare, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2017

Sensus Healthcare, Inc. reported unaudited earnings results for the first quarter ended March 31, 2017. For the quarter, the company reported revenues of $4,354,349 against $3,035,204 a year ago. The increase was primarily the result of a strong contribution from the SRT-100 Vision, which has a higher average selling price. Loss from operations was $1,588,212 against income of $9,588 a year ago. Loss before income taxes was $1,572,133 against income of $2,717 a year ago. Net loss was $1,572,133 or $0.12 per basic and diluted share against net income of $2,081 or $0.00 per basic and diluted share a year ago. Adjusted LBITDA was $1,389,985 against adjusted EBITDA of $95,365 a year ago.

Sensus Healthcare, Inc., Q1 2017 Earnings Call, May 04, 2017

Sensus Healthcare, Inc., Q1 2017 Earnings Call, May 04, 2017

Sensus Healthcare, Inc. Announces Resignation of Darell S. Rigel from the Board of Directors

On April 11, 2017, Sensus Healthcare, Inc. received notice from Dr. Darell S. Rigel, a director of the company, that he has resigned from the company's Board of Directors, effective April 11, 2017.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sensus Healthcare, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at